You are here

Merck

What to Expect from Merck’s Q1 Revenues and Earnings

Market Realist

Wed, 04/24/19 - 12:06 pm

Investors to AbbVie, J&J, Merck and more: Fork over info on pricing and executive pay

Fierce Pharma

Tue, 04/23/19 - 05:32 pm

Vertex Pharmaceuticals

Merck Wins FDA Nod for Combo Therapy in Advanced Kidney Cancer

Xconomy

Mon, 04/22/19 - 11:11 am

advanced renal cell carcinoma

Full Results of Merck’s Zerbaxa Trial Show Drug Is on Par With Meropenem as Pneumonia Treatment

BioSpace

Mon, 04/15/19 - 11:06 pm

nosocomial pneumonia

hospital-acquired pneumonia

J&J, Merck and Pfizer spent tax savings on investor payouts, not R&D: Oxfam

Fierce Pharma

Mon, 04/15/19 - 11:30 am

The data are clear: Ebola vaccine shows ‘very impressive’ performance in outbreak

Stat

Sat, 04/13/19 - 12:07 pm

FDA expands Keytruda approval for first-line NSCLC treatment

Pharmaforum

Fri, 04/12/19 - 11:26 am

non-small cell lung cancer

What the New York City Measles Emergency Means For Vaccine-Maker Merck

Motley Fool

Wed, 04/10/19 - 11:34 pm

AZ and MSD’s Lynparza gets EU nod for hard-to-treat breast cancer

Pharmaforum

Wed, 04/10/19 - 09:46 am

BRCA-mutant breast cancer

Two more Big Pharma CEOs enjoyed hefty raises in 2018, leaving the industry’s only major league female chief in firm control of last place

Endpoints

Tue, 04/9/19 - 07:08 pm

The top 15 pharma companies by 2018 revenue

Fierce Pharma

Mon, 04/8/19 - 11:30 pm

Bristol-Myers Squibb

Gilead Sciences

Teva Pharmaceutical

NGM Bio’s IPO Raises $107M as NASH Drug Continues Clinical Testing

Xconomy

Wed, 04/3/19 - 11:05 pm

NGM Biopharmaceuticals

AACR: One year after mammoth lung cancer win, Merck's Keytruda holds its own in tough-to-treat subgroups

Fierce Pharma

Mon, 04/1/19 - 12:36 pm

Despite research boom, few immunotherapy studies targeting pancreatic cancer

Biopharma Dive

Mon, 04/1/19 - 12:18 pm

pancreatic cancer

cancer immunotherapy

Bristol-Myers Squibb

Keytruda nabs key lung cancer nod in China. But are blockbuster sales really attainable?

Fierce Pharma

Sat, 03/30/19 - 12:02 am

advanced non-squamous non-small cell lung cancer

NGM Biopharmaceuticals Updates IPO Filing – Will Raise Over $122 Million

CP Wire

Tue, 03/26/19 - 09:38 am

NGM Biopharmaceuticals

NGM Biopharmaceuticals Updates IPO Filing – Will Raise Over $122 Million

Tue, 03/26/19 - 09:30 am

NGM Biopharmaceuticals

Will GSK/Tesaro’s Checkpoint Inhibitor Be Able to Compete With Merck’s Keytruda?

BioSpace

Wed, 03/20/19 - 12:27 pm

endometrial cancer

Merck doubles down on NGM Bio pact but culls obesity drug

Fierce Biotech

Wed, 03/20/19 - 12:15 pm

NGM Biopharmaceuticals

R&D round-up: Non-opioid painkiller space heats up

Pharmaforum

Sat, 03/16/19 - 12:38 pm

non-opioid pain treatments

Kings College London

Pages